International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Clonidine 0.01-mg/mL in Ora-Blend Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2021 - Volume 25, Number 5
View All Articles in Issue

Page(s): 414

Clonidine 0.01-mg/mL in Ora-Blend Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Clonidine 0.01-mg/mL in Ora-Blend Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, clonidine, central acting alpha 2 adrenergic agonist, sympathetic nervous system, formulation, oral suspension, opioid withdrawal, benzodiazepine withdrawal, alcohol withdrawal, high blood pressure, hypertension, antihypertensive agent, anxiety disorders, tic disorders, migraine, menopause, hot flashes, vasomotor symptoms, diarrhea, pain syndromes

Related Categories: FORMULATIONS, MENTAL HEALTH, PAIN MANAGEMENT, CARDIOLOGY, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Allen Loyd V Jr	Mar/Apr 2018 Pg. 146
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Cilazapril 1-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 413
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Xu Quanyun A, Trissel Lawrence A, Pham Lien	Jan/Feb 2002 Pg. 66-69
Metronidazole 50 mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 52
Quetiapine Fumarate 10 mg/mL in Ora-Blend Allen Loyd V Jr	Nov/Dec 2021 Pg. 506
Lansoprazole 3-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2022 Pg. 429
Azstarys in Ora-Blend Single Dose Allen Loyd V Jr	May/Jun 2022 Pg. 233
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Allen Loyd V Jr	Jan/Feb 1999 Pg. 25-29
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Nitazoxanide 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2023 Pg. 420
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara	May/Jun 2020 Pg. 246-251
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli	May/Jun 2020 Pg. 252-262
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H	Jan/Feb 2018 Pg. 66-75
Return to Top